Furthermore, RAB17 expression was demonstrated to be negatively correlated with immune cells infiltration, thus suggesting that RAB17 might be a potential prognostic biomarker for ccRCC patients and for estimating immunotherapy response [120]. The gene discussed is RAB17; the disease is nonpapillary renal cell carcinoma.